CD4 c.985_986delinsCC ;(p.E329P)

Variant ID: 12-6926325-GA-CC

NM_000616.4(CD4):c.985_986delinsCC;(p.E329P)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection.

Cell Host & Microbe
Brouwer, Philip J M PJM; Antanasijevic, Aleksandar A; Ronk, Adam J AJ; Müller-Kräuter, Helena H; Watanabe, Yasunori Y; Claireaux, Mathieu M; Perrett, Hailee R HR; Bijl, Tom P L TPL; Grobben, Marloes M; Umotoy, Jeffrey C JC; Schriek, Angela I AI; Burger, Judith A JA; Tejjani, Khadija K; Lloyd, Nicole M NM; Steijaert, Thijs H TH; van Haaren, Marlies M MM; Sliepen, Kwinten K; de Taeye, Steven W SW; van Gils, Marit J MJ; Crispin, Max M; Strecker, Thomas T; Bukreyev, Alexander A; Ward, Andrew B AB; Sanders, Rogier W RW
Publication Date: 2022-11-17

Variant appearance in text: CD4: E329P
PubMed Link: 36400021
Variant Present in the following documents:
  • Main text
View BVdb publication page



Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization.

Cell
Hastie, Kathryn M KM; Cross, Robert W RW; Harkins, Stephanie S SS; Zandonatti, Michelle A MA; Koval, Anatoliy P AP; Heinrich, Megan L ML; Rowland, Megan M MM; Robinson, James E JE; Geisbert, Thomas W TW; Garry, Robert F RF; Branco, Luis M LM; Saphire, Erica Ollmann EO
Publication Date: 2019-08-08

Variant appearance in text: CD4: E329P
PubMed Link: 31398326
Variant Present in the following documents:
  • Main text
View BVdb publication page